A Study of PHN-010 in Patients With Advanced Solid Tumors
Pheon Therapeutics
Pheon Therapeutics
Fusion Pharmaceuticals Inc.
Incyte Corporation
Actym Therapeutics, Inc.
Pfizer
University of Virginia
Dana-Farber Cancer Institute
Turnstone Biologics, Corp.
Seagen Inc.
Seagen Inc.
Seagen Inc.
Sotio Biotech Inc.
Astellas Pharma Inc
Molecular Templates, Inc.
National Cancer Institute (NCI)
University of Florida
Rubius Therapeutics
Sunnybrook Health Sciences Centre
Eli Lilly and Company
Washington University School of Medicine
Royal Marsden NHS Foundation Trust
Wake Forest University Health Sciences
University Health Network, Toronto
University of California, San Francisco
British Columbia Cancer Agency
University of Alabama at Birmingham